4.1 Article

A Randomized Trial Evaluating Various Administration Routes of Natalizumab in Multiple Sclerosis

Related references

Note: Only part of the references are listed.
Article Chemistry, Multidisciplinary

Microneedle-Based Intradermal Delivery Enables Rapid Lymphatic Uptake and Distribution of Protein Drugs

Alfred J. Harvey et al.

PHARMACEUTICAL RESEARCH (2011)

Article Clinical Neurology

Effects of Natalizumab on Circulating B Cells, T Regulatory Cells and Natural Killer Cells

Norman Putzki et al.

EUROPEAN NEUROLOGY (2010)

Article Immunology

Natalizumab treatment reduces endothelial activity in MS patients

Alban Millonig et al.

JOURNAL OF NEUROIMMUNOLOGY (2010)

Article Clinical Neurology

Multiple sclerosis relapses: a multivariable analysis of residual disability determinants

M. Vercellino et al.

ACTA NEUROLOGICA SCANDINAVICA (2009)

Article Allergy

Subcutaneous Administration of IgG

Melvin Berger

IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2008)

Article Medicine, General & Internal

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis

CH Polman et al.

NEW ENGLAND JOURNAL OF MEDICINE (2006)

Article Medicine, General & Internal

A controlled trial of natalizumab for relapsing multiple sclerosis.

DH Miller et al.

NEW ENGLAND JOURNAL OF MEDICINE (2003)